Cite
HARVARD Citation
Bariola, J. et al. (2021). Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Open forum infectious diseases. p. . [Online].